[Federal Register Volume 65, Number 172 (Tuesday, September 5, 2000)]
[Notices]
[Pages 53725-53726]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-22604]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-00-49]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Disease Control and
Prevention (CDC) is providing opportunity for public comment on
proposed data collection projects. To request more information on the
proposed projects or to obtain a copy of the data collection plans and
instruments, call the CDC Reports Clearance Office at (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Send comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 60 days
of this notice.
Proposed Project
Thyroid Disease in Persons Exposed to Radioactive Fallout from
Atomic Weapons Testing at the Nevada Test Site: Phase III--NEW--
National Center for Environmental Health (NCEH), Centers for Disease
Control (CDC). In 1997, the National Cancer Institute (NCI) released a
report entitled, Estimated Exposures and Thyroid Doses Received by the
American People from I-131 In Fallout Following Nevada Nuclear Bomb
Test. This report provided county-level estimates of the potential
radiation doses to the thyroid gland of American citizens resulting
from atmospheric nuclear weapons testing at the Nevada Test Site (NTS)
in the 1950's and 1960's. The Institute of Medicine (IOM) conducted a
formal peer review of the report at the request of the Department of
Health and Human Services. In the review, IOM noted that the public
might desire an assessment of the potential health impact of nuclear
weapons testing on American populations. The IOM also suggested that
further studies of the Utah residents who have participated in previous
studies of radiation exposure and thyroid disease might provide this
information.
The National Center for Environmental Health (NCEH), Centers for
Disease Control and Prevention (CDC) proposes to conduct a study of the
relation between exposure to radioactive fallout from atomic weapons
testing and the occurrence of thyroid disease on an extension of a
cohort study previously conducted by the University of Utah, Salt Lake
City, Utah. This study is designed as a follow-up to a retrospective
cohort study begun in 1965. This is the third examination (hence Phase
III) of a cohort of individuals who were children living in Washington
County, Utah, and Lincoln County, Nevada, in 1965 (Phase I) and who
were presumably exposed to fallout from above-ground nuclear weapons
testing at the Nevada Test Site in the 1950s. The cohort also includes
a control group who were children living in Graham County, Arizona, in
1966 and presumably unexposed to fallout.
The study headquarters will be at the University of Utah in Salt
Lake City, Utah. The field teams will spend the majority of their time
in the urban areas nearest the original counties if the same pattern of
migration holds that was found in Phase II. These urban areas include
St. George, Utah, the Wasatch Front in Utah, Las Vegas, Nevada,
Phoenix/Tucson, Arizona, and Denver, Colorado. In addition some time
will be spent in California as a number of subjects had relocated there
at the time of Phase II. The purposes of Phase III are three fold:
First to re-examine the participants in Phase II for occurrence of
thyroid neoplasia and other diseases since 1986. Residents of the three
counties who moved before they could be included in the original cohort
will be located and examined. Second, disease incidence will be
analyzed in addition to period prevalence as used in the Phase II
analysis. Use of incidence will allow for greater power to detect
increased risk of disease in the exposed population through the use of
person-time. Third, disease specific mortality rates for Washington
County, Utah, and a control county, Cache County, Utah, will be
compared for people who lived in these two counties during the time of
above-ground testing. This comparison will determine if the risk of
mortality in Washington County (the exposed group) is significantly
greater than Cache County (the control group). CDC/NCEH is requesting a
3-year clearance. There is no costs to respondents.
----------------------------------------------------------------------------------------------------------------
Number of
Respondents Number of responses per Average burden Total burden
respondents respondent response (hrs) (in hours)
----------------------------------------------------------------------------------------------------------------
Exposure Questionnaire.......................... 2400 1 1 2400
Questionnaire Preparation Booklet............... 2400 1 30/60 1200
Group Member Information........................ 4800 1 5/60 384
Consent Forms................................... 4800 1 10/60 816
Interview Booklet............................... 4800 1 30/60 2400
Medical History Questionnaire (male)............ 2400 1 1 2400
Medical History Questionnaire (female).......... 2400 1 1 2400
Refusal Form.................................... 48 1 5/60 4
---------------------------------------------------------------
Total hours in burden....................... .............. .............. .............. 12004
----------------------------------------------------------------------------------------------------------------
[[Page 53726]]
Dated: August 29, 2000.
Nancy Cheal,
Acting Associate Director for Policy, Planning, and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 00-22604 Filed 9-1-00; 8:45 am]
BILLING CODE 4163-18-P